IVPost
Low birthweight in newborns linked to high levels of protein that protects placenta from cell damage
- Details
- Written by Elaine Schmidt
- Category: Latest News
UCLA scientists have discovered higher levels of a protein called humanin in the placenta tissue of women who give birth to severely underweight infants. Humanin plays a role in breaking down carbohydrates and delivering nutrients to organs and muscle. The researchers suspect that levels of humanin rise to protect the fetus when the placenta fails, which is a common cause of babies being born at a below-normal weights.
UCLA receives $20 million to create state-of-the-art health sciences learning center
- Details
- Written by Jennifer Wheelock
- Category: Medical News
A $20 million commitment from Eugene and Maxine Rosenfeld will enable UCLA Health Sciences to enhance its ability to provide simulation training to future health care professionals.
UCLA Health named a leader in care for LGBTQ patients
- Details
- Written by Phil Hampton
- Category: Health News
UCLA Health is a leader in providing equitable care for patients who are lesbian, gay, bisexual, transgender or queer, according to an assessment by the Human Rights Campaign Foundation.
FDA expands approval of Blincyto for treatment of a type of leukemia in patients who have a certain risk factor for relapse
- Details
- Written by IVP
- Category: Health News
The U.S. Food and Drug Administration granted accelerated approval to Blincyto (blinatumomab) to treat adults and children with B-cell precursor acute lymphoblastic leukemia (ALL) who are in remission but still have minimal residual disease (MRD). MRD refers to the presence of cancer cells below a level that can be seen under the microscope. In patients who have achieved remission after initial treatment for this type of ALL, the presence of MRD means they have an increased risk of relapse.
FDA authorizes first fully interoperable continuous glucose monitoring system
- Details
- Written by IVPost
- Category: Health News
The U.S. Food and Drug Administration permitted marketing of the Dexcom G6 integrated continuous glucose monitoring (iCGM) system for determining blood glucose (sugar) levels in children aged two and older and adults with diabetes. This is the first type of continuous glucose monitoring system permitted by the agency to be used as part of an integrated system with other compatible medical devices and electronic interfaces, which may include automated insulin dosing systems, insulin pumps, blood glucose meters or other electronic devices used for diabetes management.
Pharmacy Owner and Pharmacist Sentenced to 160 Months in Prison for $4.3 Million Pain and Scar Cream Kickback Scheme
- Details
- Written by IVPost
- Category: Health Care Fraud
The owner of an Orlando, Florida-area pharmacy, who was also a licensed pharmacist, was sentenced today for his role in a kickback scheme involving pain and scar creams that resulted in the payment of approximately $4.3 million in false and fraudulent claims to TRICARE. TRICARE provides coverage for active duty military members and their families, as well as retired veterans.
Page 23 of 50